Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2583]

ASCO 2022: Ibrutinib improves progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma

ASCO 2022: Ibrutinib improves progression-free survival by 50% for older patients with newly diagnosed mantle cell...

ASCO 2022: Nimotuzumab significantly improves overall survival for K-Ras wild-type advanced pancreatic cancer

ASCO 2022: Nimotuzumab significantly improves overall survival for K-Ras wild-type advanced pancreatic cancer

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Age-related lung changes provide pathway for metastatic growth of dormant melanoma cancer cells

Age-related lung changes provide pathway for metastatic growth of dormant melanoma cancer cells

Ultrasound-guided microbubbles boost immunotherapy efficacy

Ultrasound-guided microbubbles boost immunotherapy efficacy

Cancer immunotherapy capable of modulating tumour immunophenotypes

Cancer immunotherapy capable of modulating tumour immunophenotypes

The paired perils of breast cancer and diabetes

The paired perils of breast cancer and diabetes

Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and stabilizing TJP1 mRNA

Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and...

Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell lung cancer patients with brain metastases

Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell lung cancer...

ECOG-ACRIN research highlights at ASCO 2022

ECOG-ACRIN research highlights at ASCO 2022

More from ecancer